Header cover image

Media Healthcare Sector

Results

2302

0 new

All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.

2302 companies

Regulus Therapeutics

Market Cap: US$546.3m

A clinical-stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States.

RGLS

US$7.91

7D

-0.5%

1Y

286.8%

Xencor

Market Cap: US$538.8m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibodies for the treatment of asthma and allergic diseases, autoimmune diseases, and cancer.

XNCR

US$7.75

7D

-4.8%

1Y

-66.9%

Butterfly Network

Market Cap: US$536.6m

Develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally.

BFLY

US$2.53

7D

10.5%

1Y

145.6%

Eton Pharmaceuticals

Market Cap: US$531.3m

A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.

ETON

US$20.04

7D

2.2%

1Y

456.7%

InnovAge Holding

Market Cap: US$530.9m

Manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities.

INNV

US$4.04

7D

-4.7%

1Y

0.4%

LifeMD

Market Cap: US$524.0m

Operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States.

LFMD

US$11.54

7D

8.5%

1Y

48.5%

Enhabit

Market Cap: US$517.5m

Provides home health and hospice services in the United States.

EHAB

US$10.45

7D

-1.5%

1Y

15.0%

OrthoPediatrics

Market Cap: US$515.9m

A medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally.

KIDS

US$21.12

7D

-7.7%

1Y

-37.6%

Stoke Therapeutics

Market Cap: US$511.0m

An early-stage biopharmaceutical company, engages in the development of treatments for severe genetic diseases by upregulating protein expression.

STOK

US$9.18

7D

-8.7%

1Y

-34.7%

Bicara Therapeutics

Market Cap: US$505.6m

A clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors.

BCAX

US$9.98

7D

-33.6%

1Y

n/a

Axogen

Market Cap: US$504.2m

Develops and commercializes technologies for peripheral nerve regeneration and repair worldwide.

AXGN

US$11.30

7D

-2.3%

1Y

70.2%

Relay Therapeutics

Market Cap: US$498.9m

Operates as a clinical-stage precision medicines company.

RLAY

US$2.85

7D

-6.6%

1Y

-57.9%

Semler Scientific

Market Cap: US$494.2m

Provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States.

SMLR

US$43.39

7D

3.6%

1Y

49.6%

Owens & Minor

Market Cap: US$494.2m

Operates as a healthcare solutions company worldwide.

OMI

US$6.59

7D

-9.7%

1Y

-61.9%

Tyra Biosciences

Market Cap: US$494.0m

A clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States.

TYRA

US$8.82

7D

-11.6%

1Y

-46.3%

Upstream Bio

Market Cap: US$492.8m

A clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders.

UPB

US$9.62

7D

5.4%

1Y

n/a

Auna

Market Cap: US$491.9m

A healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia.

AUNA

US$6.54

7D

-6.6%

1Y

-21.3%

Community Health Systems

Market Cap: US$490.9m

Owns, leases, and operates general acute care hospitals in the United States.

CYH

US$3.75

7D

-10.9%

1Y

3.6%

Maze Therapeutics

Market Cap: US$490.5m

A clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of renal, cardiovascular, related metabolic diseases, and obesity in the United States.

MAZE

US$11.20

7D

6.5%

1Y

n/a

Kura Oncology

Market Cap: US$488.3m

A clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer.

KURA

US$5.61

7D

-12.1%

1Y

-73.9%

REGENXBIO

Market Cap: US$487.1m

A clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States.

RGNX

US$9.07

7D

-9.3%

1Y

-39.4%

Virtus Health

Market Cap: AU$705.2m

Virtus Health Limited provides various healthcare services in Australia, Denmark, the United Kingdom, Ireland, and Singapore.

VRT

AU$8.10

7D

3.7%

1Y

11.0%

Allergy Therapeutics

Market Cap: UK£355.1m

A commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders.

AGY

UK£0.074

7D

3.5%

1Y

91.0%

Zenas BioPharma

Market Cap: US$478.2m

A clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies.

ZBIO

US$10.56

7D

-8.0%

1Y

n/a

Opthea

Market Cap: AU$738.8m

A clinical-stage biopharmaceutical company, develops and commercializes drugs for eye diseases in Australia and the United States.

OPT

AU$0.60

7D

0%

1Y

1.7%

Arvinas

Market Cap: US$475.2m

A clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins.

ARVN

US$6.69

7D

0.8%

1Y

-81.0%

Amylyx Pharmaceuticals

Market Cap: US$473.3m

A clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States.

AMLX

US$4.72

7D

-14.5%

1Y

176.0%

Zevra Therapeutics

Market Cap: US$473.0m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

ZVRA

US$8.45

7D

-1.9%

1Y

85.3%

Talkspace

Market Cap: US$471.8m

Operates as a virtual behavioral healthcare company that connects patients with licensed mental health providers in the United States.

TALK

US$2.95

7D

-1.7%

1Y

4.2%

SBC Medical Group Holdings

Market Cap: US$471.4m

Provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore.

SBC

US$4.60

7D

29.6%

1Y

-65.0%

Oxford Biomedica

Market Cap: UK£348.2m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

OXB

UK£3.29

7D

6.8%

1Y

4.3%

Capricor Therapeutics

Market Cap: US$468.5m

A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.

CAPR

US$10.48

7D

-4.8%

1Y

71.8%

Botanix Pharmaceuticals

Market Cap: AU$725.5m

Engages in the research and development of dermatology and antimicrobial products in Australia and the United States.

BOT

AU$0.38

7D

0%

1Y

31.0%

Theravance Biopharma

Market Cap: US$465.0m

A biopharmaceutical company, develops and commercializes of medicines in the United States.

TBPH

US$9.28

7D

-1.8%

1Y

10.3%

Castle Biosciences

Market Cap: US$464.8m

A molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett’s esophagus (BE), uveal melanoma, and mental health conditions.

CSTL

US$15.80

7D

-4.2%

1Y

-35.6%

Altimmune

Market Cap: US$463.1m

A clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases.

ALT

US$5.51

7D

-5.8%

1Y

-20.9%

Page 12 of 64